08.31.2015 | News

Allergan Successfully Completes Naurex Acquisition

Allergan has successfully completed the acquisition of Naurex Inc., a clinical-stage biopharmaceutical company developing transformative therapies for challenging disorders of the central nervous system, including depression.

Allergan acquired Naurex for a $560 million upfront payment net of cash acquired, $460 million of which is payable upon the closing of the acquisition and $100 million of which is payable by January of 2016, as well as potential R&D success-based and sales-threshold milestone payments.  

Read the full story >
Contact Allergan
Morris Corporate Center III
400 interpace parkway
Parsippany, NJ 07054
+1 (862) 261-7000
Careers at Allergan